Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.

Richards FO, Eigege A, Miri ES, Kal A, Umaru J, Pam D, Rakers LJ, Sambo Y, Danboyi J, Ibrahim B, Adelamo SE, Ogah G, Goshit D, Oyenekan OK, Mathieu E, Withers PC, Saka YA, Jiya J, Hopkins DR.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1346. doi: 10.1371/journal.pntd.0001346. Epub 2011 Oct 11.

2.

The impact of mass drug administration and long-lasting insecticidal net distribution on Wuchereria bancrofti infection in humans and mosquitoes: an observational study in northern Uganda.

Ashton RA, Kyabayinze DJ, Opio T, Auma A, Edwards T, Matwale G, Onapa A, Brooker S, Kolaczinski JH.

Parasit Vectors. 2011 Jul 15;4:134. doi: 10.1186/1756-3305-4-134.

3.

Evidence for stopping mass drug administration for lymphatic filariasis in some, but not all local government areas of Plateau and Nasarawa States, Nigeria.

King JD, Eigege A, Umaru J, Jip N, Miri E, Jiya J, Alphonsus KM, Sambo Y, Graves P, Richards F Jr.

Am J Trop Med Hyg. 2012 Aug;87(2):272-80. doi: 10.4269/ajtmh.2012.11-0718.

4.

Long-lasting insecticidal nets are synergistic with mass drug administration for interruption of lymphatic filariasis transmission in Nigeria.

Eigege A, Kal A, Miri E, Sallau A, Umaru J, Mafuyai H, Chuwang YS, Danjuma G, Danboyi J, Adelamo SE, Mancha BS, Okoeguale B, Patterson AE, Rakers L, Richards FO.

PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2508. doi: 10.1371/journal.pntd.0002508. eCollection 2013.

6.

First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.

Nana-Djeunga HC, Tchouakui M, Njitchouang GR, Tchatchueng-Mbougua JB, Nwane P, Domche A, Bopda J, Mbickmen-Tchana S, Akame J, Tarini A, Epée E, Biholong BD, Zhang Y, Tougoue JJ, Kabore A, Njiokou F, Kamgno J.

PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005633. doi: 10.1371/journal.pntd.0005633. eCollection 2017 Jun.

7.

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission.

Simonsen PE, Derua YA, Kisinza WN, Magesa SM, Malecela MN, Pedersen EM.

BMC Infect Dis. 2013 Jul 21;13:335. doi: 10.1186/1471-2334-13-335.

8.

Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.

Endeshaw T, Taye A, Tadesse Z, Katabarwa MN, Shafi O, Seid T, Richards FO Jr.

Pathog Glob Health. 2015;109(7):344-51. doi: 10.1080/20477724.2015.1103501.

9.

Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jul 29;60(29):989-91.

10.

Endpoints for lymphatic filariasis programs.

Grady CA, de Rochars MB, Direny AN, Orelus JN, Wendt J, Radday J, Mathieu E, Roberts JM, Streit TG, Addiss DG, Lammie PJ.

Emerg Infect Dis. 2007 Apr;13(4):608-10.

11.

Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.

Evans DS, Alphonsus K, Umaru J, Eigege A, Miri E, Mafuyai H, Gonzales-Peralta C, Adamani W, Pede E, Umbugadu C, Saka Y, Okoeguale B, Richards FO.

PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3113. doi: 10.1371/journal.pntd.0003113. eCollection 2014 Sep.

12.

Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria.

Richards FO Jr, Pam DD, Kal A, Gerlong GY, Onyeka J, Sambo Y, Danboyi J, Ibrahim B, Terranella A, Kumbak D, Dakul A, Lenhart A, Rakers L, Umaru J, Amadiegwu S, Withers PC Jr, Mafuyai H, Jinadu MY, Miri ES, Eigege A.

Ann Trop Med Parasitol. 2005 Mar;99(2):155-64.

PMID:
15814034
13.

Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.

Bockarie MJ, Alexander ND, Hyun P, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW.

Lancet. 1998 Jan 17;351(9097):162-8.

PMID:
9449870
14.

Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.

Modi A, Gamit S, Jesalpura BS, Kurien G, Kosambiya JK.

PLoS Negl Trop Dis. 2017 Apr 3;11(4):e0005476. doi: 10.1371/journal.pntd.0005476. eCollection 2017 Apr.

15.
16.

Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.

Ramaiah KD, Vanamail P, Yuvaraj J, Das PK.

Trans R Soc Trop Med Hyg. 2011 Aug;105(8):431-7. doi: 10.1016/j.trstmh.2011.04.006. Epub 2011 May 23.

PMID:
21601901
17.

Prevalence of lymphatic filariasis in a tea garden worker population of Dibrugarh (Assam), India after six rounds of mass drug administration.

Khan AM, Dutta P, Sarmah CK, Baruah NK, Das S, Pathak AK, Sarmah P, Hussain ME, Mahanta J.

J Vector Borne Dis. 2015 Dec;52(4):314-20.

18.

Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control.

Njenga SM, Mwandawiro CS, Wamae CN, Mukoko DA, Omar AA, Shimada M, Bockarie MJ, Molyneux DH.

Parasit Vectors. 2011 May 25;4:90. doi: 10.1186/1756-3305-4-90.

19.

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.

Simonsen PE, Pedersen EM, Rwegoshora RT, Malecela MN, Derua YA, Magesa SM.

PLoS Negl Trop Dis. 2010 Jun 1;4(6):e696. doi: 10.1371/journal.pntd.0000696.

20.

The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.

El-Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, Ramzy RM, Shannon WD, Weil GJ.

Am J Trop Med Hyg. 2007 Dec;77(6):1069-73.

Supplemental Content

Support Center